Covestor’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Covestor's PFE Position: Q2 2026 in Review
Covestor reduced its Pfizer (PFE) stake by 13% in Q2 2026, selling an estimated $22K and leaving 5,829 shares worth $140K. The position accounts for 0.08% of the portfolio, ranked #214.
Covestor first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $426K in Q4 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Covestor held 5,829 shares of Pfizer worth $140K as of Q2 2026.
- Covestor sold 842 Pfizer shares in Q2 2026, an estimated $22K.
- Pfizer made up 0.08% of Covestor's portfolio in Q2 2026, its #214 holding.
- Covestor first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- Covestor's Pfizer position peaked at $426K in Q4 2022.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.